Xeljanz snags FDA approval for ulcerative colitis

[anonymous]

Pfizer blockbuster drug Xeljanz has won itself a new regulatory approval to treat adults with inflammatory bowel disease (IBD). This recent approval will help propel the company’s sales significantly. Pfizer’s Xeljanz is the first and only JAK inhibitor that obtained the FDA’s blessing to treat intestinal diseases. https://news.alphastreet.com/pfizer...nz-snags-fda-approval-for-ulcerative-colitis/

 

[anonymous]

Pfizer blockbuster drug Xeljanz has won itself a new regulatory approval to treat adults with inflammatory bowel disease (IBD). This recent approval will help propel the company’s sales significantly. Pfizer’s Xeljanz is the first and only JAK inhibitor that obtained the FDA’s blessing to treat intestinal diseases. https://news.alphastreet.com/pfizer...nz-snags-fda-approval-for-ulcerative-colitis/

Oh, goody, goody. Now we’ll be last in this class, too. Watch the price skyrocket, and we’ll be asked why it’s not selling.

 

[anonymous]

Great win for us, but lets be honest - Abbive owns the payers. OWNs.

It will take 24-48 months to get past a double step edit. They sowed this market shut.